Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.
The hormone, relaxin, inhibits aberrant myofibroblast differentiation and collagen deposition by disrupting the TGF-β1/Smad2 axis, via its cognate receptor, Relaxin Family Peptide Receptor 1 (RXFP1), extracellular signal-regulated kinase (ERK)1/2 phosphorylation (pERK) and a neuronal nitric oxide (N...
Main Authors: | Bryna Suet Man Chow, Elaine Guo Yan Chew, Chongxin Zhao, Ross A D Bathgate, Tim D Hewitson, Chrishan S Samuel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22936987/pdf/?tool=EBI |
Similar Items
-
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
by: Martina Kocan, et al.
Published: (2017-06-01) -
Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3
by: Ross eBathgate, et al.
Published: (2013-02-01) -
The role of relaxin-3/RXFP3 system in hyperphagia
by: De Avila Dal'Bo, Camila
Published: (2019) -
The role of the relaxin receptor RXFP1 in brain cancer
by: Kunanuvat, Usakorn
Published: (2013) -
The role of the relaxin receptor RXFP1 in brain cancer
by: Kunanuvat, Usakorn
Published: (2013)